NCT04631991

Brief Summary

Non-pathological high myopia patients and controls undergoing a comprehensive ophthalmologic examination are included. The Optical Coherence Tomography Angiography (OCTA) software automatically segments these full-thickness retinal scans into the superficial and deep inner retinal vascular plexuses, outer retina, and choriocapillaris (CC). The vascular density in the superficial and deep retinal vascular zones is calculated automatically by the software, and the foveal avascular zone (FAZ) and foveal density (FD) are also automatically determined. Choroidal thickness is calculated manually by two retinal specialists, and the average value was used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

November 11, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 17, 2020

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2020

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2020

Completed
Last Updated

January 14, 2021

Status Verified

January 1, 2021

Enrollment Period

25 days

First QC Date

November 11, 2020

Last Update Submit

January 13, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Optic nerve head vessel density

    Optic nerve head vessel density assessed with optical coherence tomography angiography

    10 minutes

Secondary Outcomes (4)

  • Choriocapillaris flow area

    10 minutes

  • Subfoveal choroidal thickness

    10 minutes

  • Foveal avascular zone

    10 minutes

  • Subfoveal central macular thickness

    10 minutes

Study Arms (2)

Non-pathological high myopia

Comprehensive ophthalmologic examination

Diagnostic Test: Comprehensive ophthalmologic examination

Control

Comprehensive ophthalmologic examination

Diagnostic Test: Comprehensive ophthalmologic examination

Interventions

Measurements of best-corrected visual acuity, refractive error, intraocular pressure, axial length, slit lamp examination of the anterior segment, dilated fundus examination, and optical coherence tomography angiography imaging.

ControlNon-pathological high myopia

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Study population includes a convenience sampling from the patients admitted to outpatient clinic between November 2020 and December 2020.

You may qualify if:

  • Patients with category 0 (no myopic retinopathy lesions)
  • Patients with category 1 (tessellated fundus)

You may not qualify if:

  • poor image quality (signal strength index (SSI) \<60) due to unstable fixation
  • IOP \>21 mm Hg; logMAR \> 0.1
  • pre-existing ophthalmic pathologies
  • prior ocular surgery
  • systemic chronic disease which can cause retinopathy
  • such as diabetes mellitus, hypertension etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aslı Çentinkaya Yaprak

Antalya, 070059, Turkey (Türkiye)

Location

Related Publications (1)

  • Yaprak AC, Yaprak L. Retinal microvasculature and optic disc alterations in non-pathological high myopia with optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2021 Nov;259(11):3221-3227. doi: 10.1007/s00417-021-05216-x. Epub 2021 May 7.

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 11, 2020

First Posted

November 17, 2020

Study Start

November 10, 2020

Primary Completion

December 5, 2020

Study Completion

December 8, 2020

Last Updated

January 14, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations